IDENTIFICATION OF PATIENTS WITH RECURRENT GBM THAT BENEFIT FROM BEVACIZUMAB

BACKGROUND: (blind field). METHODS: RNA expression profiling was performed using DASL (Illumina) on 185 samples of which 113 were derived from BELOB trial samples and 72 were used to test the performance of the platform. RNA sequencing was performed on 96 samples, 78 of which were from BELOB trial s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: French, Pim, Erdem-Eraslan, L., Kros, J.M., Oosterkamp, H.M., Walenkamp, A.M.E., Beerepoot, L., Hanse, M., Buter, J., Honkoop, A., van der Holt, B., Vernhout, R.M., Sillevis Smitt, P.A.E., Taal, W., van den Bent, M.J.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4144494/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou206.29
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados